Victoria Atkins
Main Page: Victoria Atkins (Conservative - Louth and Horncastle)Department Debates - View all Victoria Atkins's debates with the Home Office
(6 years, 1 month ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is a pleasure to serve under your chairmanship, Sir Edward. As I have previously stated on the record, owing to the potential for a conflict of interest, with my husband’s business interests, I have recused myself on issues relating to cannabis and synthetic cannabinoids. I therefore will not respond to those points during this debate, but will ask the Policing Minister, who deals with these matters, to write to Members on those points.
I congratulate the hon. Member for Inverclyde (Ronnie Cowan) on securing the debate. His debates on drugs always seem to be interrupted by numerous Divisions, so I am delighted to have reached the point where I have a little time to sum up.
This Government recognise the serious harm that drugs cause, not only to individual users but to their families, children and local communities. Drugs have been identified in the recent serious violence strategy as a major driver of the recent increases in serious violence. Drugs cost more than £10 billion a year to our society, over half of which is attributed to drug-related acquisitive crime such as burglary, robbery and shoplifting. We remain ambitious and committed in addressing these problems. That is why we committed to further action on drugs as part of the serious violence strategy.
Our policy on drugs is anchored in education to reduce demand, tough and intelligent enforcement to restrict supply, evidence-based treatment to aid recovery, and co-ordinated global action. I will deal with the global picture first. The UK is driving global action to tackle drug harms. Genuine international challenges include the increased production and purity of cocaine in Colombia, and the problems of fentanyl use in North America. International co-operation is key. We continue to strengthen controls at our borders, share information and understand global trends. Last week, I met people from the International Narcotics Control Board who had come to view our work on tackling drugs. We will continue to work closely with our international partners to share best practice and achieve the best possible outcomes for all those at risk of harm from drugs.
The national picture, Government are already delivering a range of action is that through the 2017 drugs strategy to prevent drug misuse in our communities, support people to recover from dependence on drugs, and support law enforcement to tackle the illicit drug trade.
On reducing drug dependency, is the Minister aware that generic buprenorphine is no longer available from the manufacturer? As a result, drug treatment uses the Subutex brand, which costs £3,000 per patient per year and is becoming increasingly expensive. Will she look into that? It is proving financially difficult to support patients with opioid-substitution therapy.
I will of course look into that, and I will ask a Health Minister to write to my hon. Friend.
The drug strategy recognises that we must reduce demand by acting early to prevent people from using drugs in the first place and to prevent escalation to more harmful use. We are taking action to build resilience among young people, alongside a targeted approach for groups at particular risk. Well-off recreational drug users must also recognise the part that they play in funding the criminal networks that supply their drugs and the violence that those crime gangs use.
My shadow, the hon. Member for Swansea East (Carolyn Harris), has already mentioned the issue of county lines. Yesterday, we had a meeting of the serious violence taskforce. It is absolutely clear that the illicit drug market is a major driver of the rise of serious violence, which is why the police must work with our health professionals to tackle it. Schools play a vital role in that, helping children to understand the risks of illicit drugs and build their resilience and ability to say no. The Government are making health education compulsory, as well as funding Mentor UK’s Alcohol and Drug Education and Prevention Information Service to provide practical advice to teachers.
Tough enforcement, however, is fundamental. We are restricting the supply of drugs, adapting our approach to changes in criminal activity, using innovative data and technology, and taking co-ordinated action to tackle drugs alongside other criminal activity. Through the Psychoactive Substances Act 2016, we have choked off the supply of so-called legal highs. More than 300 retailers throughout the UK have closed down or are no longer selling psychoactive substances. Police have arrested suppliers, and the National Crime Agency has ensured the removal of psychoactive substances from sale on UK websites.
Yet those substances have been replaced by others, which are possibly more damaging, such as Spice and Mamba. We are not solving the problem; all we are doing is pushing it around the table.
Interestingly, the hon. Gentleman raised the issue of decriminalisation, and I again note that no single body of opinion has formed about how such decriminalisation would work. Who would administer the drugs, presumably available on the NHS to users? Will that include recreational drugs such as MDMA, so that people can have fun at the weekend? Is the taxpayer paying for that?
I welcome the chance to discuss the issue, but the problem with such a debate is that “decriminalisation” is referred to, but not a body of opinion—certainly none described in this debate—to evidence of what would happen under such a policy. The police and others have to deal with precisely these issues day to day, to protect our communities from illicit drug use, because those drugs harm people.
The Minister is setting out the case for why there is an obstacle to change. In Durham, for example, the police and crime commissioner, a very experienced chief constable and all the agencies say, “Give this a try.” They believe that it will work, because the evidence suggests that. Why does she not pilot such a scheme?
One or two police and crime commissioners may say that—I know, because they write to me regularly—but the majority of them do not share that view. That is not to say that we cannot have a debate about this, but let us please not pretend that that is the view of the Association of Police and Crime Commissioners.
Recovery is a vital element of our approach. We are taking forward action to enhance treatment quality and outcomes. Here is perhaps where some colleagues have—inadvertently I am sure—fallen into error when talking about drug consumption rooms and heroin-assisted treatment. Sometimes, people may not understand the differences between the two programmes. We have run pilot heroin-assisted treatment programmes, where heroin users are put into an intensive support programme through their GPs or other medical professionals. They are prescribed diamorphine as part of an intensive programme of action. That is very different from drug consumption rooms, which support the illicit drug market.
I will not, as I am conscious of time. People wander into drug consumption rooms, having bought their fixes on the street. We have no guarantees on the safety of those substances. The Government simply cannot condone that sort of behaviour, not least because it falls foul of the Misuse of Drugs Act 1971, but also because it would not be responsible to support the illegal market.
The Government say they cannot condone that, but what lessons are they taking from the view of the International Narcotics Control Board?
Interestingly, the view of the International Narcotics Control Board is very cautious. It says that drug consumption rooms must be operated
“within a framework that offers treatment and rehabilitation services”.
I would argue that its model is closer to heroin-assisted treatment.
I have one minute left, so I am afraid I will have to refuse more interventions.
We are helping users through needle and syringe programmes, to prevent infections, and opioid-substitution therapy, and widening the use of naloxone. The Home Secretary has commissioned an independent review of the drugs market in the 21st century—it is not quite the prohibition of alcohol in the 1920s, as the hon. Member for Inverclyde represented. We need to understand how the drugs market works today. That is why, as part of our drugs strategy and our serious violence strategy, working with health partners, we are convinced that this is the right approach.